← Open Payments lookup

KIMBERLY WACHTER: Open Payments

NPI 1851481071 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$895 in 20 payments from 8 companies in 2025. Trend: 2023 $494 · 2024 $856 · 2025 $895

Food & beverage: $895
CompanyPaymentsAmount
Edwards Lifesciences Corporation7$541
Boston Scientific Corporation2$118
Actelion Pharmaceuticals US, Inc.3$69
Chiesi USA, Inc.2$58
AstraZeneca Pharmaceuticals LP2$36
Boehringer Ingelheim Pharmaceuticals, Inc.1$30
Novartis Pharmaceuticals Corporation2$27
SCPHARMACEUTICALS INC.1$16

Products named: WATCHMAN FLX, OPSUMIT, FARXIGA, JARDIANCE, KENGREAL, CLEVIPREX, LEQVIO, FUROSCIX.

Industry payments across MD — which companies pay providers there.